Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

PathoVacs Inc
Profile last edited on: 10/3/2017      CAGE: 5SAC3      UEI: GAEYBFGAB1N9

Business Identifier: Universal Microbial Vaccines
Year Founded
2009
First Award
2012
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1024 Roy J Carver Co-Laboratory
Ames, IA 50011
   (781) 244-4505
   information@pathovacs.com
   www.pathovacs.com
Location: Single
Congr. District: 04
County: Story

Public Profile

PathoVacs is based on a vaccine development technology referred known as PELS (Proteomics-based Expression Library Screening). PELS reduces the cost and timeframe of antigen discovery – the crucial and first major component of vaccine development. This Demonstration Fund award will assist the company in advancing the experimental vaccine through clinical trials, manufacturing and distribution

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
2
Conversion Rate
40.00%
Phase I Dollars
$842,383
Phase II Dollars
$1,625,605
Total Awarded
$2,467,988

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 2 USDA $749,545
Project Title: Broadly protective porcine Streptococcus suis vaccines
2022 1 NIH $393,833
Project Title: A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
2020 2 CBD $1,125,110
Project Title: Circulating Diagnostic Markers of Infectious Disease
2012 1 USDA $99,750
Project Title: Immunologically Cross Reactive Proteins for Broadly Protective Campylobacter Chicken Vaccines
2012 1 USDA $99,750
Project Title: Immunologically Cross Reactive Proteins for Broadly Protective Campylobacter Chicken Vaccines

Key People / Management

  Manohar John -- President

  John Manohar

Company News

Oct 04 2013
Harrisvaccines awarded grant for swine disease research